ESR1 and breast carcinoma: Some well characterized examples include estrogen receptor (ER)-positive breast cancer, where estrogens that promote tumor development are blocked therapeutically, and androgen-dependent prostate cancer, where androgen deprivation helps to suppress tumor progression.